课题基金 / 基金详情

Development of risk assessment system for human by environmental disruptants using nuclear hormone receptor

Development of risk assessment system for human by environmental disruptants using nuclear hormone receptor
利用核激素受体开发环境破坏者对人类的风险评估系统
批准号:
11839021
负责人:
DOI Rikuo
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2001

项目摘要

项目成果

DOI Rikuo的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Endocrine disruptants are thought to have various effects on various organs. Estrogenic responses by endocrine disruptants were analyzed using eukaryotic cells and yeast, which are overexpressing human estrogen receptors. In wildlife, some species such as seagulls contaminated with large amount of environmental pollutants showed thyroid hyperplasia and thyroid tumors. To address the effects on thyroid hormone system by endocrine disruptants, the HeLaTR cells that constitutively overexpressed thyroid hormone receptor were constructed and analyzed. Luciferase activity was induced by the addition of T3 in HeLaTR cells transfected with the plasmid containing thyroid hormone response element as an enhancer. Bisphenol A and 2-diethylhexyl phtalate, both could bind to estrogen receptor, had no effect on the luciferase activity, but hydroxylated PCB repressed the luciferase activity caused by the addition of T3. In contrast, dioxin enhanced the luciferase activity, however dioxin alone caused no effect on the activity. These results suggested that HeLaTR cells could be used as the tool for thyroid hormone action by endocrine disruptants.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ISOLATION OF mRNA 5'-CAPPING ENZYME FROM THE PATHOGENIC FUNGUS CANDIDA ALBICANS AND SCREENING FOR SPECIFIC INHIBITORS OF THE ENZYME
  • 批准号:
    07670408
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $1.47万
  • 财政年份:
    1995
  • 负责人:
    DOI Rikuo
  • 依托单位:
Genetical and toxicological studies for evaluation of clinical tests in individualities
A STUDY ON INDIVIDUAL DIFFERENCES IN CLINICAL BLOOD TEST VALUES.
海外基金